Shop

für Versicherte der IK Innovationskasse

​PSM (Prostate Status Management)

€850,00
In stock
Product Details

PSM (Prostate Status Management)


Around 45% of patients initially diagnosed with prostate cancer only have a slow-growing form of the cancer. In this case, active surveillance is recommended in order to treat only patients with aggressive prostate cancer.
With the protexam PSM test, aggressive prostate cancer can be detected at an early stage.

  • Take a urine sample at home - simple + discreet
  • CE-compliant laboratory diagnostics
  • High analysis accuracy
  • Clinically tested
  • Result within 2-3 working days of sample receipt
  • VAT-exempt according to §4 No.14a UStG
Share this product with your friends
​PSM (Prostate Status Management)
Share by: